Functional potential of Aloe vera juice against CCl4 induced hepatotoxicity in animal model

The present study was designed to evaluate functional potential of Aloe vera juice against (CCl4 induced) hepatotoxicity using animal model. Biochemical analyses including liver, renal enzymes, bone biomarkers and lipid profile were conducted after 4 weeks of oral Aloe vera juice administration. Liver enzymes, AST, ALP and total bilirubin were reduced up to 15-7%, 60-32.52% and 29-48%, respectively in Aloe vera juice treated rats i.e., 10 mL/kg and 20 mL/kg doses. Reduction in serum cholesterol (8%), LDL (12%) and triglycerides (15%) were observed. Urea was significantly reduced up to 11% which further reduced up to 30% at higher dose. Increased content of serum proteins (23-50%) and albumin (40-116%) were found at the different doses. Vitamin D was found maximum in G4 i.e., 38.63 mg/dL as compared to lowest i.e., 5.12 mg/dL in G2, similarly improvement in calcium i.e., 11-22% was observed in G3 and G4. The serum oxidative stress markers indicated raised superoxide dismutase (9%), glutathione (15%), catalase (9%) and reduced lipid peroxidation 78% at higher concentration of Aloe vera juice consumption. In addition, histological evaluation also depicted positive impact on hepatic and renal portfolio in all treated rats. All of the findings enlighten the potential of Aloe vera juice as a functional beverage.

Automated summary

The present study aimed to investigate the functional potential of Aloe vera juice against CCl4-induced hepatotoxicity using an animal model. After 4 weeks of oral administration of Aloe vera juice, various biochemical analyses were conducted. The results showed that Aloe vera juice reduced liver enzymes, total bilirubin, serum cholesterol, LDL, and triglycerides levels. It also increased serum proteins, albumin, and improved bone biomarkers. Furthermore, Aloe vera juice consumption reduced oxidative stress markers and had positive effects on liver and renal health.